Effects of combined low‐dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non‐invasive indices of steatosis and fibrosis, and adipokine levels in non‐alcoholic fatty liver disease: a randomized controlled trial-Reference-Cited by-同舟云学术

Effects of combined low‐dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non‐invasive indices of steatosis and fibrosis, and adipokine levels in non‐alcoholic fatty liver disease: a randomized controlled trial

Published:2017-07-10 Issue:12 Volume:19 Page:1805-1809
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Polyzos Stergios A.¹^ORCID,Kountouras Jannis¹,Mantzoros Christos S.²,Polymerou Vaia³,Katsinelos Panagiotis¹

Affiliation:

1. Second Medical Clinic, School of MedicineAristotle University of Thessaloniki Thessaloniki Greece

2. Division of Endocrinology, Diabetes and MetabolismBeth Israel Deaconess Medical Center, Harvard Medical School Boston Massachusetts

3. Department of Biopathology, Biomedicine Laboratories Athens Greece

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12989

Reference19 articles.

1. Nonalcoholic Fatty Liver Disease

2. Emerging and future therapies for nonalcoholic steatohepatitis in adults

3. Current therapeutic strategies in non-alcoholic fatty liver disease

4. Effects of short-term energy restriction on liver lipid content and inflammatory status in severely obese adults: Results of a randomized controlled trial using 2 dietary approaches

5. Long-term effect of exercise on improving fatty liver and cardiovascular risk factors in obese adults: A 1-year follow-up study

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spironolactone Reduces the Risk of Death in Veterans With Heart Failure With Preserved Ejection Fraction;Journal of the American Heart Association;2024-07-16

2. Regulation of Fructose Metabolism in Nonalcoholic Fatty Liver Disease;Biomolecules;2024-07-13

3. The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review;Antioxidants;2024-06-29

4. Effects of Combined Low-Dose Spironolactone Plus Vitamin E versus Vitamin E Monotherapy on Lipidomic Profile in Non-Alcoholic Fatty Liver Disease: A Post Hoc Analysis of a Randomized Controlled Trial;Journal of Clinical Medicine;2024-06-28

5. Review of current and new drugs for the treatment of metabolic-associated fatty liver disease;Hepatology International;2024-06-08